Literature DB >> 21934071

Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.

Mirjam Kool1, Corine Geurtsvankessel, Femke Muskens, Fillipe Branco Madeira, Menno van Nimwegen, Harmjan Kuipers, Kris Thielemans, Henk C Hoogsteden, Hamida Hammad, Bart N Lambrecht.   

Abstract

Subsets of antigen-presenting cDCs have a differential capacity to present exogenous and endogenous protein antigens to CD4(+) and/or CD8(+) T lymphocytes, depending on expression of antigen-uptake receptors, processing machinery, and microbial instruction. pDCs are also capable of antigen presentation, but the conditions under which they do this have not been systematically addressed. Highly purified cDCs and pDCs were exposed to exogenous, soluble OVA peptide or whole protein. Alternatively, they were made to express cytoplasmic or endosomal OVA by retroviral transduction or by infection with influenza virus containing OVA epitopes. Like cDCs, pDCs expressed the MHC I processing machinery and could present endogenous or cross-present exogenous OVA to CD8(+) T cells, provided they had been stimulated by CpG motif TLR9 ligands or by influenza. Unlike cDCs, the cross-priming activity of pDCs was enhanced, not decreased, by simultaneous TLR stimulation. Processing and presentation of exogenous OVA to CD4(+) T cells required TLR9 ligation prior to antigen encounter and addition of OVA-specific Igs. These stimuli up-regulated critical MHC II processing machinery and enhanced routing to acidic endosomal organelles in a FcγRII-dependent manner. Endogenous antigen was not presented to CD4(+) T cells when expressed in the cytoplasm of pDCs by retrovirus or contained in influenza, unless an Ii-chain-derived endosomal routing signal was present. Thus, timing of TLR ligation and facilitated antigen uptake dictate the potential of pDCs to present endogenous or exogenous antigen by influencing endosomal traffic and antigen-processing machinery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934071     DOI: 10.1189/jlb.0610342

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  23 in total

Review 1.  Clinical view on the importance of dendritic cells in asthma.

Authors:  Rohit Gaurav; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-10       Impact factor: 4.473

Review 2.  The function of Fcγ receptors in dendritic cells and macrophages.

Authors:  Martin Guilliams; Pierre Bruhns; Yvan Saeys; Hamida Hammad; Bart N Lambrecht
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

Review 3.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

4.  Basophils as a primary inducer of the T helper type 2 immunity in ovalbumin-induced allergic airway inflammation.

Authors:  Wenwei Zhong; Wen Su; Yanjie Zhang; Qi Liu; Jinhong Wu; Caixia Di; Zili Zhang; Zhenwei Xia
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 5.  Plasmacytoid dendritic cells in HIV infection.

Authors:  Meagan O'Brien; Olivier Manches; Nina Bhardwaj
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

7.  A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.

Authors:  Melissa A Kachura; Colin Hickle; Sariah A Kell; Atul Sathe; Carlo Calacsan; Radwan Kiwan; Brian Hall; Robert Milley; Gary Ott; Robert L Coffman; Holger Kanzler; John D Campbell
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

8.  Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.

Authors:  Kerrie J Sandgren; Anna Smed-Sörensen; Mattias N Forsell; Martina Soldemo; William C Adams; Frank Liang; Leif Perbeck; Richard A Koup; Richard T Wyatt; Gunilla B Karlsson Hedestam; Karin Loré
Journal:  J Immunol       Date:  2013-05-31       Impact factor: 5.422

Review 9.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013

10.  Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.

Authors:  Leslie Guéry; Stéphanie Hugues
Journal:  Front Immunol       Date:  2013-03-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.